Ardelyx Inc (ARDX)
8.72
+1.93
(+28.42%)
USD |
NASDAQ |
May 03, 16:00
8.70
-0.02
(-0.23%)
After-Hours: 20:00
Ardelyx Max Drawdown (5Y): 95.33% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 95.33% |
| March 31, 2024 | 95.33% |
| February 29, 2024 | 95.33% |
| January 31, 2024 | 95.33% |
| December 31, 2023 | 95.33% |
| November 30, 2023 | 95.33% |
| October 31, 2023 | 95.33% |
| September 30, 2023 | 95.33% |
| August 31, 2023 | 95.33% |
| July 31, 2023 | 95.33% |
| June 30, 2023 | 95.33% |
| May 31, 2023 | 95.33% |
| April 30, 2023 | 95.33% |
| March 31, 2023 | 95.33% |
| February 28, 2023 | 95.33% |
| January 31, 2023 | 95.33% |
| December 31, 2022 | 95.33% |
| November 30, 2022 | 95.33% |
| October 31, 2022 | 95.33% |
| September 30, 2022 | 95.33% |
| August 31, 2022 | 95.33% |
| July 31, 2022 | 95.33% |
| June 30, 2022 | 95.33% |
| May 31, 2022 | 95.33% |
| April 30, 2022 | 95.33% |
| Date | Value |
|---|---|
| March 31, 2022 | 95.33% |
| February 28, 2022 | 95.33% |
| January 31, 2022 | 94.95% |
| December 31, 2021 | 94.95% |
| November 30, 2021 | 94.95% |
| October 31, 2021 | 94.95% |
| September 30, 2021 | 94.95% |
| August 31, 2021 | 94.95% |
| July 31, 2021 | 94.95% |
| June 30, 2021 | 94.95% |
| May 31, 2021 | 94.95% |
| April 30, 2021 | 94.95% |
| March 31, 2021 | 94.95% |
| February 28, 2021 | 94.95% |
| January 31, 2021 | 94.95% |
| December 31, 2020 | 94.95% |
| November 30, 2020 | 94.95% |
| October 31, 2020 | 94.95% |
| September 30, 2020 | 94.95% |
| August 31, 2020 | 94.95% |
| July 31, 2020 | 94.95% |
| June 30, 2020 | 94.95% |
| May 31, 2020 | 94.95% |
| April 30, 2020 | 94.95% |
| March 31, 2020 | 94.95% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
94.95%
Minimum
May 2019
95.33%
Maximum
Feb 2022
95.12%
Average
94.95%
Median
May 2019
Max Drawdown (5Y) Benchmarks
| Nektar Therapeutics | 99.30% |
| Rigel Pharmaceuticals Inc | 86.40% |
| Omeros Corp | 95.41% |
| Vistagen Therapeutics Inc | 98.38% |
| Karyopharm Therapeutics Inc | 97.56% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 1.748 |
| Beta (5Y) | 0.8694 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 95.93% |
| Historical Sharpe Ratio (5Y) | 0.1192 |
| Historical Sortino (5Y) | 0.2128 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.88% |